Variant report
Variant | nsv890887 |
---|---|
Chromosome Location | chr8:51816730-51929846 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:85)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr8:51853747-51854039 | IMR90 | lung: | n/a | n/a |
2 | CEBPB | chr8:51853745-51854060 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CEBPB | chr8:51853777-51854033 | A549 | lung: | n/a | n/a |
4 | CTCF | chr8:51856671-51856989 | T-47D | breast: | n/a | n/a |
5 | CTCF | chr8:51913389-51913420 | GM10266 | blood: | n/a | n/a |
6 | CTCF | chr8:51860171-51860176 | LNCaP | prostate: | n/a | n/a |
7 | CTCF | chr8:51865763-51865828 | GM10266 | blood: | n/a | n/a |
8 | CTCF | chr8:51832477-51832604 | Spleen_OC | spleen: | n/a | n/a |
9 | CTCF | chr8:51885340-51885490 | Caco-2 | colon: | n/a | n/a |
10 | CTCF | chr8:51856871-51856889 | MCF-7 | breast: | n/a | n/a |
11 | CTCF | chr8:51856980-51857130 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr8:51901176-51901215 | GM20000 | blood: | n/a | n/a |
13 | CTCF | chr8:51856872-51856953 | LNCaP | prostate: | n/a | n/a |
14 | E2F4 | chr8:51842582-51842805 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | E2F4 | chr8:51919099-51919441 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | E2F4 | chr8:51918023-51918214 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | E2F4 | chr8:51895598-51895784 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | E2F4 | chr8:51893910-51894441 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FAM48A | chr8:51834461-51834598 | GM12878 | blood: | n/a | n/a |
20 | FAM48A | chr8:51879216-51879319 | GM12878 | blood: | n/a | n/a |
21 | FOS | chr8:51842972-51843295 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | FOS | chr8:51841960-51842306 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr8:51842959-51843298 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | FOS | chr8:51841968-51842344 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | FOS | chr8:51842970-51843253 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | FOS | chr8:51842970-51843313 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | FOS | chr8:51891261-51891401 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | GATA3 | chr8:51894177-51894271 | SH-SY5Y | brain: | n/a | n/a |
29 | IRF3 | chr8:51824975-51825136 | GM12878 | blood: | n/a | n/a |
30 | MAFF | chr8:51847802-51847895 | HepG2 | liver: | n/a | n/a |
31 | MAFK | chr8:51926513-51926537 | K562 | blood: | n/a | n/a |
32 | MAFK | chr8:51905888-51906021 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | MAZ | chr8:51848045-51848060 | HepG2 | liver: | n/a | n/a |
34 | MAZ | chr8:51896730-51896733 | HepG2 | liver: | n/a | n/a |
35 | MAZ | chr8:51853064-51853065 | HepG2 | liver: | n/a | n/a |
36 | MXI1 | chr8:51835406-51835516 | K562 | blood: | n/a | n/a |
37 | MYC | chr8:51904905-51904933 | GM12878 | blood: | n/a | n/a |
38 | MYC | chr8:51920542-51920582 | H1-hESC | embryonic stem cell: | n/a | n/a |
39 | MYC | chr8:51869445-51869478 | H1-hESC | embryonic stem cell: | n/a | n/a |
40 | MYC | chr8:51860036-51860114 | GM12878 | blood: | n/a | n/a |
41 | MYC | chr8:51904785-51904938 | H1-hESC | embryonic stem cell: | n/a | n/a |
42 | POLR2A | chr8:51918045-51918198 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | POLR2A | chr8:51873599-51873705 | GM12878 | blood: | n/a | n/a |
44 | POLR2A | chr8:51834854-51835014 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | POLR2A | chr8:51912613-51912879 | H1-neurons | neurons: | n/a | n/a |
46 | POLR2A | chr8:51875959-51875970 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | POLR2A | chr8:51836647-51836741 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | POLR2A | chr8:51822802-51823002 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | POLR2A | chr8:51886660-51886852 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | POLR2A | chr8:51856863-51856866 | MCF-7 | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000201316 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6473485 | chr8:51816730-51816731 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs576510873 | chr8:51816740-51816741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs578096311 | chr8:51816762-51816763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545302996 | chr8:51816769-51816770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563043452 | chr8:51816806-51816807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182644037 | chr8:51816808-51816809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11994633 | chr8:51816908-51816909 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs560502907 | chr8:51816940-51816941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528097156 | chr8:51816941-51816942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs6473486 | chr8:51817045-51817046 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs574453776 | chr8:51817125-51817126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374022657 | chr8:51817135-51817136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7842618 | chr8:51817170-51817171 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs570153031 | chr8:51817189-51817190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530985145 | chr8:51817201-51817202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549500564 | chr8:51817217-51817218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567622178 | chr8:51817228-51817229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567062573 | chr8:51817274-51817275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187008761 | chr8:51817277-51817278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73576010 | chr8:51817308-51817309 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs116515004 | chr8:51823403-51823404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1905529 | chr8:51823442-51823443 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs562896445 | chr8:51823462-51823463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530442052 | chr8:51823479-51823480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542895300 | chr8:51823501-51823502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561058676 | chr8:51823580-51823581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528289956 | chr8:51823641-51823642 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375391083 | chr8:51823679-51823680 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565263552 | chr8:51823698-51823699 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72647198 | chr8:51823745-51823746 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571477251 | chr8:51823756-51823757 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146814644 | chr8:51823854-51823855 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183512117 | chr8:51823940-51823941 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187717994 | chr8:51823969-51823970 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192871249 | chr8:51823980-51823981 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556003315 | chr8:51823988-51823989 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148988669 | chr8:51824035-51824036 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35036316 | chr8:51824043-51824044 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553248462 | chr8:51824061-51824062 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199903130 | chr8:51824159-51824160 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577817705 | chr8:51824168-51824169 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35860906 | chr8:51824176-51824177 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs143755779 | chr8:51824229-51824230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553714326 | chr8:51824239-51824240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556674244 | chr8:51824254-51824255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574874433 | chr8:51824268-51824269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34952955 | chr8:51824293-51824294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs398007764 | chr8:51824295-51824296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184964046 | chr8:51824337-51824338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532622435 | chr8:51824388-51824389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
22q11 deletion syndrome | 20357662 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51816400-51817400 | Enhancers | Fetal Lung | lung |
2 | chr8:51823400-51823600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr8:51823600-51824200 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr8:51823600-51824200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr8:51824200-51825000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr8:51834200-51836800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr8:51836200-51836600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr8:51842200-51842800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr8:51846800-51847200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr8:51857000-51859400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr8:51885000-51885400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
12 | chr8:51885200-51886000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr8:51897800-51899000 | Enhancers | Dnd41 | blood |